Major osteoarthritis research featured in NY Times
Stephanie Bryant is leading a $33.57 million federal grant to reverse osteoarthritis, and the New York Times is taking notice.
NY Times has published an article on tissue regeneration research being lead by Bryant, a professor in the Department of Chemical and Biological Engineering and director of the Materials Science and Engineering Program at the University of Colorado Boulder.
Bryant, an expert in functional tissue engineering and biomaterials, said the goal of the work is “to return the tissue to a healthy state,” with at most one injection.
Her team has identified an existing drug already approved by the Food and Drug Administration and is applying it to treat osteoarthritis. Bryant and her colleagues developed a patented particle delivery system that can be injected into the joint and provide intermittent bursts of the drug for months.
With phase one successfully complete, the team is now advancing to of the research. If successful, human trials would follow.